Peg-filgrastim and cabazitaxel in prostate cancer patients. [electronic resource]
Producer: 20130509Description: 84-9 p. digitalISSN:- 1473-5741
- Aged
- Antineoplastic Agents -- adverse effects
- Disease-Free Survival
- Fever -- chemically induced
- Filgrastim
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Humans
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Neoplasm Metastasis
- Neutropenia -- chemically induced
- Neutrophils -- metabolism
- Polyethylene Glycols
- Prostatic Neoplasms -- drug therapy
- Recombinant Proteins -- therapeutic use
- Retrospective Studies
- Survival Rate
- Taxoids -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.